MiR-21 and MiR-155 Expressions in Oral Squamous Cell Carcinoma: A Retrospective Study in Mexican Patients using FFPE Biopsies

miR-21 和 miR-155 在口腔鳞状细胞癌中的表达:一项基于墨西哥患者 FFPE 活检组织的回顾性研究

阅读:1

Abstract

AIM: Oral squamous cell carcinoma (OSCC) is a prevalent malignancy with poor survival outcomes, particularly in regions with high tobacco use and less early detection. MicroRNAs (miRNAs) such as miR-21 and miR-155 have been implicated in tumor progression and viral oncogenesis. This study aimed to evaluate the expressions of miR-21 and miR-155 in OSCC tissues and their association with histological differentiation and HPV infection in a Mexican population. MATERIALS AND METHODS: This retrospective cross-sectional study included 30 OSCC cases and 30 age- and sex-matched healthy oral tissue controls. Total RNA was extracted from formalin-fixed paraffin-embedded tissue samples, and miR-21 and miR-155 levels were quantified using RT-qPCR. HPV genotyping (types 16 and 18) was performed via endpoint PCR. Statistical analysis included Mann-Whitney U test, Kruskal-Wallis test, and Fisher's exact test. Effect sizes were calculated using Glass's delta, and a significance level of P < 0.05 was applied. RESULTS: MiR-21 and miR-155 were significantly upregulated in OSCC tissues compared to controls (P < 0.001 for both), with large effect sizes (Glass's δ = 3.78 and 2.63, respectively). No significant association was found between miRNA expression levels and tumor differentiation grade (P > 0.05). HPV was detected in 26.6% of OSCC samples, with HPV-16 being the most frequent subtype. A significant association was observed between HPV positivity and tobacco use (P = 0.002), but not with miRNA expression levels. CONCLUSION: The overexpression of miR-21 and miR-155 in OSCC supports their potential as diagnostic biomarkers in oral cancer. While their levels were not significantly associated with tumor grade or HPV status, their consistent elevation in malignant tissues warrants further investigation into their mechanistic role in OSCC pathogenesis and their applicability in biomarker panels for early detection, especially in Latin American populations.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。